InsiderClue
Insiders · Profile

CHASE WILLIAM J

Director at Intellia Therapeutics · EVP, Finance & Administration at AbbVie. Filing since 3 Mar 2014. CIK 0001563572

NTLA Intellia Therapeutics, Inc. Director · 1 trade ABBV AbbVie EVP, Finance & Administration · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
20 Aug 2025
Director
Bought
100,000
$1.00M
288%
ABBV AbbVie
26 Jun 2019
EVP, Finance & Administration
Bought
30,400
$2.05M
21.8%
ABBV AbbVie
12 Dec 2018
EVP, Finance & Administration
Sold, plan not stated
60,000
$5.40M
36.4%
ABBV AbbVie
1 Mar 2018
EVP, Chief Financial Officer
Sold, plan not stated
32,400
$3.71M
16.4%
ABBV AbbVie
28 Feb 2018
EVP, Chief Financial Officer
Sold, plan not stated
38,528
$4.60M
18.9%
ABBV AbbVie
18 May 2017
EVP, Chief Financial Officer
Sold, plan not stated
38,300
$2.50M
17.3%
ABBV AbbVie
2 Dec 2016
EVP, Chief Financial Officer
Sold, plan not stated
6,600
$390.65K
3.7%
ABBV AbbVie
22 Dec 2014
EVP, Chief Financial Officer
Sold, plan not stated
8,495
$577.66K
4.5%
ABBV AbbVie
3 Mar 2014
EVP, Chief Financial Officer
Sold, plan not stated
3,948
$198.26K
2.1%
9 decisions on file.